BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Summit Therapeutics Inc. (NASDAQ:SMMT)

3 posts

Biotech NewsIs Summit Therapeutics (SMMT) a Smart Biotech Stock to Buy Before the Crowd Notices?

  • BioTech Health X
  • June 21, 2026
We recently published our article Top 5 Healthcare Stocks That Could Turn a $1000 Investment Into Something Bigger.…
0 Shares
0
0
0
0
0
0
0

Biotech NewsTop 5 Healthcare Stocks That Could Turn a $1000 Investment Into Something Bigger

  • BioTech Health X
  • June 21, 2026
In this article, we break down the Top 5 Healthcare Stocks That Could Turn a $1,000 Investment Into…
0 Shares
0
0
0
0
0
0
0

Biotech NewsSummit Therapeutics (SMMT)’s Ivonescimab Shows Global Success—Analysts See Billions Ahead

  • BioTech Health X
  • August 26, 2025
Summit Therapeutics Inc. (NASDAQ:SMMT) is a clinical-stage biopharmaceutical company that has steadily carved out its position as one…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • 5 Biotech Stocks That Could Turn Medicine Into Wall Street’s Next Gold Rush
  • 10 Biotech Stocks That Could Turn Medicine Into Wall Street’s Next Gold Rush
  • Is Eli Lilly (LLY) Still a Good Buy After Its Massive Stock Market Run?
  • Is Johnson & Johnson (JNJ) Still One of the Safest Healthcare Stocks to Buy?
  • Is Pfizer (PFE) Finally a Good Stock to Buy After Its Big Pullback?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • July 4, 2026
    5 Biotech Stocks That Could Turn Medicine Into Wall Street’s Next Gold Rush
    • July 4, 2026
    10 Biotech Stocks That Could Turn Medicine Into Wall Street’s Next Gold Rush
    • June 28, 2026
    Is Eli Lilly (LLY) Still a Good Buy After Its Massive Stock Market Run?
    • June 28, 2026
    Is Johnson & Johnson (JNJ) Still One of the Safest Healthcare Stocks to Buy?
    • June 28, 2026
    Is Pfizer (PFE) Finally a Good Stock to Buy After Its Big Pullback?
Recent Posts
  • Could Stryker Corp. (SYK) Be a Smart Long-Term Buy in Healthcare Equipment?
    • June 28, 2026
  • Is Regeneron Pharmaceuticals (REGN) Still a Smart Biotech Stock to Buy?
    • June 28, 2026
  • Could DexCom (DXCM) Be a Smart Long-Term Buy in Medical Devices?
    • June 28, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (1,004)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top